Comparison of the efficacy and safety of insulin degludec/aspart (twice‐daily injections), insulin glargine 300 U/mL, and insulin glulisine (basal–bolus therapy)

AIMS/INTRODUCTION: We compared the efficacy and safety of insulin degludec/aspart (IDegAsp) twice‐daily injections with insulin glargine 300 U/mL and insulin glulisine basal–bolus therapy (Gla300/Glu) using insulin glargine 300 U/mL (Gla300) and insulin glulisine (Glu). MATERIALS AND METHODS: A tota...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawaguchi, Yuji, Sawa, Jun, Hamai, Chie, Nishimura, Yuri, Kumeda, Yasuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825933/
https://www.ncbi.nlm.nih.gov/pubmed/30868726
http://dx.doi.org/10.1111/jdi.13038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825933/
https://www.ncbi.nlm.nih.gov/pubmed/30868726
http://dx.doi.org/10.1111/jdi.13038

Ejemplares similares